Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr;29(2):342-344.
doi: 10.3350/cmh.2023.0106. Epub 2023 Mar 16.

Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences

Affiliations
Editorial

Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences

Tian Yang et al. Clin Mol Hepatol. 2023 Apr.
No abstract available

Keywords: China; Hepatectomy; Hepatocellular carcinoma; Immunotherapy; Molecular targeted therapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

Comment on

References

    1. Yang T, Lu JH, Wu MC. Hepatocellular carcinoma in China. BMJ (Clinical research ed.) 2010;340:c1026.
    1. Yang T, Zhang H, Lau WY, Shen F, Wu MC. Liver disease in China: A long way to go. Hepatology. 2015;62:1640. - PubMed
    1. Xie D, Shi J, Zhou J, Fan J, Gao Q. Clinical practice guideline and real-life practice in hepatocellular carcinoma: Chinese perspective. Clin Mol Hepatol. 2023;29:206–216. - PMC - PubMed
    1. Fan R, Papatheodoridis G, Sun J, Innes H, Toyoda H, Xie Q, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J Hepatol. 2020;73:1368–1378. - PubMed
    1. Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition) Liver Cancer. 2018;7:235–260. - PMC - PubMed